ç§ã¯42æ³ã§ã2017幎3æã«èºããã«åºäŒãã6æã«è «ç転移ãçºçããŸããã ã¢ã¡ãªã«ã®å人ã®ã¢ããã€ã¹ã§ãã¡ãããŠã³ãHEALTH(ãŠãã€ãããã¡ãã£ã«ã«ãã³ã)ããçµã³ã€ããŠããŸãã ããŒããŒã倧åŠéå±ããµãã¥ãŒã»ããç·åç é¢ããã»ã³ã¿ãŒææãç±³åœèšåºè «çåŠäŒèºããèšåºã¬ã€ãã©ã€ã³åäŒäŒé·ãç±³åœèºããå°é家ã¯ãªã¹ã¿ãŒã¬ãŒGã¢ãŸãªMDãæšèŠããŸããã ã¢ã¡ãªã«ã§æãæåãªèºããæ²»çã»ã³ã¿ãŒã®æåãªå»åž«ãšæãã€ãªãã§ãèºãããšæŠãããã«ãç§ã¯èªåã®éåœã®ãã¹ã¿ãŒã«ãªããŸã!
â â â
æã¿åã
01. ç§ã¯42æ³ã§ãæªãç掻ç¿æ
£ããªããäœèª¿ã¯è¯å¥œã§ãã 2017幎3æãŸã§èºããã«èŠã€ãããªãã£ãã
02. 2017幎5æã«åœå ã§æè¡ãåãã6æã«PET-CTãåæ€æ»ããé žéšãªã³ãç¯ã«è «ç転移ã®çããèªããã
03. å€åœäººã®å人ã¯ãç§ãã¢ã¡ãªã«ã®èºããã®å°é家ã«çžè«ããããšããããšãææ¡ãããã®åŸãç§ã¯ã¢ã¡ãªã«ã®èºããã®ãããç é¢ããŒããŒã倧åŠä»å±ããµãã¥ãŒã»ããç·åç é¢ãèŠã€ããŸããã Azzoliã¯ãç±³åœèºçã®å°é家ã§ãããç±³åœèšåºè «çåŠäŒ(ASCO)èºçæ²»çã¬ã€ãã©ã€ã³å§å¡äŒã®å§å¡é·ã§ãã
04. ç§ã®åŠ»ã¯ããã¹ãŠã®åœå å»çèšé²ãææ°ã®ç»åæ€æ»ã¬ããŒããç çåŠã¬ããŒããªã©ã®æ å ±ãæŽçããç±³åœé£éŠå»åŠé£åã«æåºããè±èªã«ç¿»èš³ããã¯ã©ãŠããã©ãããã©ãŒã ãä»ããŠç±³åœã®èºããã®å°é家Drã«éä¿¡ããŸããã Azzoliã ãã®åŸãã¢ã¡ãªã«ã®èºããå°éå»Drãåãå ¥ããŸããã Azzoliãããªçžè«ã®æåã®ã©ãŠã³ã;
05. ç±³åœã®èºããå°éå»Dr. Azzoliã¯ãç§ã®ã±ãŒã¹æ å ±ãåãåã£ãåŸãç§ã®è³ªåã«åºã¥ããŠãé·ãã±ãŒã¹è§£éã¬ããŒãã«ç§ã«å¿çããŸããã
06. ç±³åœã®èºããå°éå»Drãšçµã¿åããã. Azzoliã¯ãåœå ã®å»åž«ãç§ã®ããã«ç©æ¥µçã«æ²»çãããšå ±åããŸããã åŸææ²»çã決å®ããããã«ãæã ã¯Drã«åãããŸãã Azzoliã¯ãããªçžè«ãç³è«ãã2017幎6æã«ãŠãã€ãããã»ã¡ãã£ã«ã«ã»ã«ã¹ããªãŒã«ãã£ãŠæé ãããŸããã
07. ãããªçžè«äžã®ç±³åœã®èºçã®å°é家Dr. Azzoliã¯ãèºçã®æšçæ²»çãšèºçã®å
ç«çæ³ãé©çšãããã©ãããåæããæŸå°ç·çæ³ãšååŠçæ³ãæšå¥šããŸããã
08. 6æäžæ¬ãã9æäžæ¬ã«ãããŠãç§ã¯4ãµã€ã¯ã«ã®ååŠçæ³ãéå§ãã7æäžæ¬ãã9æäžæ¬ãŸã§ãååŠçæ³+èžéšæŸå°ç·çæ³ã¯33åã10æäžæ¬ãã10ææ«ãŸã§ã¯é éšã®æŸå°ç·äºé²ã10åè¡ã£ãã
09. è «çã¯æããã«çž®å°ããå šèº«ã®ä»ã®å Žæã§ã¯è «ç転移ã¯èªããããã転äœã®çãã®ãããªã³ãç¯ãçž®å°ããã
10. 11æããããªçžè«ä»¥æ¥ã®æ²»ççµéšãšçµæãæŽçããç±³åœã®èºçå°éå»Drã«æž¡ããã ã¢ãŸãªã¯ãç±³åœã®èºããã®å°é家DrãåŸãã Azzoliã®2çªç®ã®æžé¢ã«ããã¬ããŒãã¯ãåã³ç§ã®æ²»çèšç»ã«æå³ã®ããææ¡ãããŸããã
11. ç§ã®è©±ãå ±æããããšã¯ãç§ã®ããã«æŠã£ãŠãã人ã ãææã®èºãããå æããããã«ãã倧ããªåžæãåŸãããã«äœãããã
â â â
ç§ã®ä»äº
ç§ã¯ã42æ³ãå«ç ã飲é ãæéœã®åŠ»ãšç掻ããæ¯å¹Žå®æçã«å¥åº·èšºæãåããèèªèã®ããããé€ããŠãä»ã®å¥åº·äžã®åé¡ã¯ãããŸããã 40ãšèšããšãç§ã¯åžžã«ãã®å¹Žéœ¢ã§å€ãã®ããšãèŠãŠã89ãã€ã³ããç解ããçã®ãããªãã絶æçãªãã®ãèŠãæ¹æ³ãç¥ã£ãŠãããšæããŸãã
確ãã«èšºæ
2017幎3æ
å³ããå§ãã颚éªè¬ã飲ãã§ããŸã è¯ããªã£ãŠããªãã ãã®åŸãå¥åº·èšºæã§CTãæ®ããšãå»è ãç§ã®æ ç»ãèŠãŠãé¡ãæ²ããšãç§ã®å¿ã¯æ°·ã®ã»ã©ãŒã«èœã¡ãŸããã CTæèŠã¯å·Šèº1.8cm倧ç å€ãš3cmãµã€ãºã®çžŠæšªãªã³ãç¯ãšå·Šèºéãªã³ãç¯ã瀺ããã
ç æ°ã¯æ²»çã®ããã«æ»ã£ãŠãç§ã¯æéœã§æé«ã®ç é¢ã«å ¥é¢ããåæã¯å ç§ãå€ç§ãç»åãæ€æ»ç§ãªã©ãæ°ãåããªãã»ã©ã®éšéã§æ¯æ¥èµ°ãåã£ãŠããŸããã ç é¢ã¯ããµã€ã¬ã³ãã§ããªãã®æéã殺ããããªãã®å¿èã®ã»ãšãã©ãæ¶è²»ããåŸã ã«äžæ©å«ãªçµ¶æçãªåŽé¢ã瀺ãããšã匷å¶ããå Žæã§ãã
2017幎5æ
ç§ã¯å€ç§çæ²»çãåããã 麻é ãç®èŠããåŸãç§ã¯åŸ®ç¬ã¿ãæµ®ãã¹ãŠãããã ã¯ç§ã«çç±ãå°ããç§ã¯ã¡ããã©ãã®æ°æéã§æé«ã®ç¡ç ãåã£ããšèšããŸããã è¡åŸãç§ã®ç æ°ã®çµæã¯ãã決å®çã§ããã æè¡ç çæèŠã¯èºçãšã,å±æãªã³ãç¯ã«è «ç现èã¯èªããããªãã£ãã,11矀ã®ç·ç¶ãªã³ãçµç¹ã«çµç¯ãèªããã
2017幎6æ
6æã®åæ€æ»ã§ã¯ãç§ã®éŠã®ãªã³ãç¯ã«è «ç転移ããã£ãããã§ã! ãããŠãããã¯éåžžã«åä»ãªäœçœ®ã§ãããéŠã®å€ç§å»ã¯ããªã³ãç¯ãå°ãããããšèãããã®æ§è³ªãæ確ã§ã¯ãªããæè¡ãæ£è ã®éŠã®å€å·ã«å€§ãããå¿ ãããæè¡ã§ãã®é åãèŠã€ããããšãã§ããªãã®ã§ãå»åž«ã¯æè¡ããå§ãããŸããã
å€ãæ·±ããšãç§ã¯éã«æ¯ãåããŠãç§ã®äººçã¯ãããªã«æ©ãçµããã«è¿ã¥ããŠããã®ã§ãããã? ç§ã¯æ°ã«ããªãã
ç§ã¯å»è ãšç¥ãåãã§ã
ããããç§ã¯äžçããæãããŠããŸãã æ§åãç§ã®ããšãç¥ã£ãåŸãã¢ã¡ãªã«ã¯äžçã§æãå»åŠãçºéããå°åã ãšç§ã«èšã£ãã ç°¡åãªèšèã¯ãå°ãªããšã絶æã®ç§ã«å¥ã®ãªãã·ã§ã³ãæäŸããã¢ã€ãã¢ã¯åºå£ã決å®ããŸããç§ã¯ä»¥åãäžåœã®å€§ããªç é¢ã¯çµããã®ããã«ã¯èŠããªããšæã£ãã
ããããçµå±ãæµ·å€ã«è¡ãã®ã¯äºããªããšã§ã¯ãªãããéã¯å°ãããç æ°ãé ãããŠããã ããããä»ã®ãšãããæ²»çã®ããã«æµ·å€ã«è¡ãããšã¯ãç§ãçããå¯äžã®åžæã§ãã ã ããæã ã¯ç¬¬äžæ¬¡äžç倧æŠã«èãåããããšã«ããŸããã ãŸãã劻ãšç§ã¯ãç§ãç§ã®èºãããèŠã«è¡ãããã«ã¢ã¡ãªã«ã®ã©ã®ç é¢ã«è¡ãã¹ããã確èªããå¿ èŠããããŸãã
ã¢ã¡ãªã«ã®ç é¢ã«ã€ããŠäœãç¥ããªãããå人ãç§ãç解ãå§ããã®ãå©ããŸããã ãŸããç é¢ã®æ§ã ãªã©ã³ãã³ã°ããªã³ã©ã€ã³ã§ãã§ãã¯ããããŸãã«ãå€ãããã¹ãŠãæé«ã ãšèšããç§ã¯éžæããããšã¯ã§ããŸããã å®éã劻ãšç§ã¯èºãããå¿é ããŠãããã©ã®å€åœã®ç é¢ãèºããæ²»çãå¹ççã§ãæ²»çæ¹æ³ãå€ããå°é家ã®æš©åšããããèºããç 究ã«å€é¡ã®è³éãæå ¥ãããŠããããã©ã®ç é¢ãæš©åšãããšä¿¡ããŠããŸãã
ç¡åãªæã«éãã«æ¯ããŠããã奥æ§ã«å¿ããæè¬ããŠããŸãã
ã€ã³ã¿ãŒãããäžã«ã¯æ å ±ãå€ããããããæçšãªè³æãå¹ççã«æœåºããããšã¯ã§ããŸããã ãã®åŸãã¢ã¡ãªã«ã®å人ã¯ãç±³åœå»åž«ã®æš©åšããæé«è³ã®1ã€ã§ããæš©åšããå»çè©äŸ¡æ©é¢ã§ããã«ã¹ã¯ã«ãŒãªãšè©±ããŸããã èªå® ã«ã¯ã圌ãšååããæ©é¢ã§ããã¡ãããŠã³ãããããŸãã ã ãããç§ã¯ãã®ãã©ãããã©ãŒã ããŠãã€ãããã¡ãã£ã«ã«ã«éžã³ãŸããã ããŒããŒã倧åŠéå±ããµãã¥ãŒã»ããç·åç é¢
æã
ã¯ãMGHã1925幎ã«äžçåã®è
«çã¯ãªããã¯ãèšç«ããå»åŠçã«äžè¬çã«äœ¿çšãããŠããXç·ãMRIãPET-CTã¯ããã®ç
é¢ãäžçäžã§æåã«äœ¿çšããããã®åŸãæ§ã
ãªåœã«åºããããŸããç
é¢ãçã®éºäŒåæ€æ»ãšã¿ã€ãã³ã°ãäžçã§åããŠå®æœããèºçæ£è
ãã»ãŒç¥ã£ãŠããã€ãªã·ã£ãç 究æã®ç 究éçºã§ããããšãåŠã³ãŸãããEGFRãALKããã®ä»ã®éºäŒåå€ç°ãç
é¢ã§æåã«çºèŠãããç
é¢ã¯ç±³åœåã®ãããã³ãã€ãæŸå°ç·æ²»çã»ã³ã¿ãŒãæã£ãŠããŸã(ç§ãšåŠ»ã¯ãäžæµ·ã®æå°è
ããããã³ã»ã³ã¿ãŒãæµ·å€ã«èšªåããã®ãèŠãŠãå»åŠãç解ããŠããªãããã®æè¡ã¯èºããã«æçšã§ããã¹ãã ãšçµè«ã¥ãã)ã
ç é¢ã®èšåãè¯ãããšãå°é家ãèŠåŠããå¿ èŠããããŸãã Dr. ã«ã€ã㊠Azzoliã¯ãç±³åœã®å人ã¯ã圌ãç±³åœèšåºè «çåŠäŒ(ASCO)èºçæ²»çã¬ã€ãã©ã€ã³å§å¡äŒã®è°é·ã§ãããåœéèºçæ²»çã¬ã€ãã©ã€ã³ãéçºããæé«æš©åšããå°é家ã§ããããšãç¥ããŸããã ãããã£ãŠãæã ã¯ãããµãã¥ãŒã»ããç·åç é¢èºçã»ã³ã¿ãŒã¯ãç±³åœã§æãæš©åšããèºçæ²»çã»ã³ã¿ãŒã§ãããšä¿¡ããŠããŸãã
ãŠãã€ãããã®å»çã¹ã¿ããã¯ãç±³åœãžã®èšªåã¯é«äŸ¡ã§ãããäºåã«ç¹å¥ãªæ¹æ³ã§èšªåããããšãæ€èšããããšãã§ãããšç§ã«èšããŸãã - ãããªçžè«ã
å»åž«ãšã®äŒè°
2017幎6æ20æ¥
ãã®æ¥ã¯ç§ãã¡ã«ãšã£ãŠéåžžã«ç¹å¥ã§ãã åããŠã¢ã¡ãªã«ã®èºããã®å°é家DrãååŸããåã«. Azzoliã®æžé¢ã«ããå ±åã®åŸãæã ã¯åã³ç±³åœã®èºããã®å°é家Drã«è©±ããŸããã Azzoliã¯ãããªçžè«ãç³è«ããçžè«ã¯ãã®æ¥ã«äºå®ãããŠããŸãã 劻ã¯ç§ã®ããã«ãã®äŒè°ã«åºåžããåœå ã®äž»æ²»å»ãåå ããŸããã åæã®ç±³åœã®èºçã®å°é家Dr. Azzoliã¯ããã¹ãŠã®ç§ã®åœå æ²»çã®å»çèšé²ãææ°ã®ç»åæ€æ»ã¬ããŒããç çåŠã¬ããŒããªã©ããŠãã€ãããã®ã¹ã¿ãããéããŠå ¥æããŸããã
ãããªçžè«ã¯30åãŸã§ç¶ãã質åããèªç±æéããã¹ãŠã§ãã
çµ±åãããç±³åœã®èºçã®å°é家Dr. Azzoliã®æåã®æžé¢ã«ããå ±å:æ£è ãåŸãèºçã¯ã転移ã®å¯èœæ§ãé«ãé«ã¬ãã«ã®çã§ãããç転移æ§åçºãèµ·ãããšãã»ãšãã©æ²»çããªãã®ã§ãæŸå°ç·ååŠçæ³ãåããæãæ¥ãã劻ãšç§ã¯ååŠçæ³ã®ææã«èºèºããŠãããã圌ãããèšãã®ãèãããšããç§ã¯æ±ºæãåºããã ãã®åŸãç±³åœã®èºããå°éå»Dr. Azzoliã¯ã圌ãç§ã®ããã«äœã£ãååŠçæ³ã®ã¬ãžã¡ã³ãäžããç§ã®è «ããéŠã®ãªã³ãç¯ãèãããšã圌ã¯ç«ã¡äžãã£ãŠãç§ã¯èžã®æŸå°ç·çæ³ãšé éšäºé²æŸå°ç·çæ³ã®äž¡æ¹ãåããªããã°ãªããªãããšã瀺åããŸããã
ç±³åœã®èºããå°éå»Dr. Azzoliã¯ãçŸåšç±³åœã§æµè¡ããŠããèºçæšçæ²»çããã³èºçå ç«çæ³ã®ç§ã®çŸæ£ãžã®é©çšæ§ãæšçè¬ããã³å ç«è¬ã®äœ¿çšã«é¢ãã泚æäºé ãç±³åœã§çŸåšå®æœãããŠããèºçèšåºè©Šéšãããã³ç±³åœèšåºè©Šéšãžã®ç§ã®åå ã®é·æãšçæãåæããã
ç±³åœã®èºããå°éå»Dr. ãèºçã®æšçæ²»çã¯ãäž»ã«è «çãåŒãèµ·ããå€ç°éºäŒåã«äœçšããè¬ç©çæ³ã§ããããšAzzoliã¯è¿°ã¹ãã æ£è ã®ç¶æ³ãèãããšãçŸæç¹ã§ã¯ãè¬ç©æšçãèŠã€ãã確çã¯3%~5%ã«éããªããšæããŸãã
ç±³åœã®èºããå°éå»Dr. å ç«çæ³ã¯çŸåšãèºããã«å¿çšãããŠããããšAzzoliã¯èšãã èºçã®å ç«çæ³ã¯ãèºçã®æšçæ²»çãããå¹æçã§ãããšæããŸãã FDAãæ¿èªããæ£è ããåŸãããèºçã®å ç«çæ³è¬ã¯ãããŸããã ãããããã§ãŒãºèšåºè©Šéšã®çµæã¯ããã®è¬ãèºçããã³èžè ºçã«äœçšããããšã瀺ããŠããã ç±³åœã§ã¯ãèºããæ£è ã«ãã®è¬ãæçšããæš©éããããŸãã
ç±³åœã®èºããå°éå»Dr. Azzoliã¯ãæ£è ã®å®éã®ç¶æ³ã®é¢ã§ã¯ãæ£è ã¯çŸåšãæšæºçãªãã·ã¹ãã©ãã³+ãã¢ã·ã³äœµçšè£å©ååŠçæ³ãå¿ èŠãšãããšèšããŸããã è£å©ååŠçæ³ãšæŸå°ç·çæ³(該åœããå Žå)ãã¿ã€ã ãªãŒã«åããããå Žåãé«ãæ²»çã®å¯èœæ§ããããæ£è ããã®å°é£ãä¹ãåãããšãé¡ã£ãŠããŸãã
ãã®ããã«ãç§ã¯åŸã ã«æŸå°ç·ååŠçæ³ãåãå§ãããã®å³ã¯èªç¶ã«èšãå¿ èŠã¯ãããŸããã
2017幎11æ
11æãç§ã®æ²»ççµéšãšçµæã®ã»ãŒ4ã¶æã¯ãç±³åœã®èºããã®å°é家Drã«éãããŸããã Azzoliã ç±³åœã®èºããå°éå»DrãåŸãã Azzoliã®2çªç®ã®æžé¢ã«ããã¬ããŒãã ç±³åœã®èºããå°éå»Dr. Azzoliã¯ãã»ãŒ4ã¶æã®æ²»çå¹æã確èªããç§ã®è «çã¯ãçŸåšã®æŸå°ç·ååŠçæ³ã¬ãžã¡ã³ãå®è¡å¯èœã§ãããå¯äœçšãå¶åŸ¡å¯èœã§ããããšã瀺ãçž®å°ã®å åãæã£ãŠããŸã! ãããã£ãŠãç¹å¥ãªå€æŽã¯å¿ èŠãããŸããããå¯æ¥ãªãã©ããŒã¢ãããç¶æããå¿ èŠããããŸãã ç±³åœã®èºããå°éå»Dr. ã¢ãŸãªã¯å ±åæžã®äžã§ãããã¯æ°žç¶çãªæŠãã§ãããããªãã¯ããã«åºå·ãããã®æŠãã«åå©ããããšãã§ãããšä¿¡ããŠããŸãã
人çã¯ããã¹ããã©ãã«ããã®ããåºãã£ãŠããŸã! ããããåžæã決ããŠãããããã誀ã£ãŠããŠãã€ãããã¯ç§ã«åžæã®çªãéããŸããã ç§ã®çµéšãå ±æããããšã§ãç§ã¯ç§ãšåãåºäŒããæã£ãŠãã人ã«åžæãäžãããã ãã§ãã
ç±³åœã®æš©åšããæåãªå»çè©äŸ¡æ©é¢ã®æŠç¥çããŒãããŒãšããŠããŠãã€ãããã»ã¡ãã£ã«ã«ã»ã³ãŒãã¬ãŒã·ã§ã³ã¯ãç±³åœã®ããã5%ã®æå 端ã®å»çè³æºã«äŸæ ããäžåœã®æ£è ã«åžå°çŸæ£æ²»çã®åéã§æãæš©åšããããæå 端ã®å»çæ å ±ãããããç¶ããŠããŸãã ç§ãã¡ã¯ãã€ã³ã¿ãŒãããäžå¿ã®å»åž«ãšæ£è ã®ã³ãã¥ãã±ãŒã·ã§ã³ãšé éã«ãŠã³ã»ãªã³ã°ãã©ãããã©ãŒã ã«ã³ãããããç±³åœã®ãããTOP5%ã72ã®å°éãªãŒãå»åž«ãªãœãŒã¹ãäžåœãšã¢ã¡ãªã«ã®å»çæ¥ç¶ã®ã¡ãã»ã³ãžã£ãŒãè¡ãããšã«ã³ãããããŠããŸãã æ£è ãšå®¶æã«å ãªãå å®ãªå¿ãäžãã!
___________________________
泚:äžèšã®èšè¿°ã¯ãæ£è ã®åæãåŸãŠå ¬éãããŸãã
Medebound HEALTHã«ã€ããŠ
ã¡ãããŠã³ãHEALTH(https://www.medeboundhealth.com)ã¯ãç±³åœã®å»åž«ãé«åºŠãªæ²»çæ³ãšæµ·å€ã®æ£è /å»åž«ãçµã³ã€ããããšã«çŠç¹ãåœãŠãã°ããŒãã«é éå»çäŒç€Ÿã§ãã ããã¯ãå®å šãªå»çšç»å/èšé²ç¿»èš³ãäŒéãé éã«ãŠã³ã»ãªã³ã°ãä¿é²ããç¬èªã®HIPAAæºæ ã®ãã€ãªã³ã¬ã«é éå»çãã©ãããã©ãŒã ãäœæããããšã«ãã£ãŠéæãããŸãã ãã®é«åºŠã«å·®å¥åãããå»åž«ãããã¯ãŒã¯ãšãã€ãªã³ã¬ã«ã®ITãã©ãããã©ãŒã ãšåŒ·åãªãšã°ãŒã¯ãã£ãããŒã ã«ãããMedeboundã¯ã¢ãžã¢ã®äž»èŠç é¢ã»ã³ã¿ãŒãä¿éºäŒç€Ÿãªã©ã®é¡§å®¢ã®éã§å€§ããªåžå Žé åãç²åŸããŠããŸãã Medebound HEALTHã®ã¯ãã¹ããŒããŒé éçžè«ãã©ãããã©ãŒã ã«ãããå°åã®ããæ£è ã¯ã¯ãªãã¯ããã ãã§ç±³åœã®ããå°é家ã«çžè«ã§ããå»è¬åç©æµã·ã¹ãã ãéããŠé«åºŠãªå»è¬åã«ç°¡åã«ã¢ã¯ã»ã¹ã§ããŸãã